Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

December 31, 2012

Study Completion Date

April 30, 2013

Conditions
Exudative Age-Related Macular DegenerationFocal Vitreomacular Adhesion
Interventions
DRUG

Ocriplasmin

ocriplasmin intravitreal injection (125 µg)

DRUG

Sham injection

Sham injection

Trial Locations (27)

15212

Allegheny Ophthalmic & Orbital Associates, PC, Pittsburgh

30909

Southeast Retina Center, PC, Augusta

33880

Center for Retina and Maculla Disease, Winter Haven

37660

Southeastern Retina Associates, Kingsport

55435

VitreoRetinal Surgery, PA, Minneapolis

57701

Black Hills Regional Eye Institute, Rapid City

75015

Centre Ophtalmologique d'Imagerie et de Laser, Paris

78503

Valley Retina Institute, McAllen

78730

Retinal Consultants of Houston,, Houston

80045

University of Colorado Denver, Aurora

80336

Augenklinik der Ludwig Maximilians Universität München, München

90211

Retina-Vitreous Associates Medical Group, Beverly Hills

95819

Retinal Consultants Medical Group, Sacramento

08901

Retina-Vitreous Center, PA, New Brunswick

B-3300

U.Z. Leuven St. Rafaël Hospital, Leuven

F-69003

Rabelais Ophthalmologic Center, Lyon

F-13008

Centre Paradis-Monticelli, Marseille

F75006

Centre Ophtalmologique de L'Odeon, Paris

D-53127

Universität Bonn Augenklinik, Bonn

D-23538

Universität Lübeck Universitätsklinikum Schleswig-Holstein, Lübeck

D-35043

Klinik für Augenheilkunde, Universitätsklinikum Gießen, Standort Marburg, Marburg

Unknown

"University of Milan Department of Clinical Science Luigi Sacco", Milan

I-00168

Largo Agostino Gemelli (University Hospital) Institute of Ophthalmology, Rome

GU16 7UJ

Frimley Park Hospital, Frimley

L7 8XP

Royal Liverpool & Broadgreen Hospital, Liverpool

EC1V 2PD

Moorfields Eye Hospital, London

WV10 0QP

Wolverhampton Eye Infirmary New Cross Hospital, Wolverhampton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

ThromboGenics

INDUSTRY